Fu, X. Et Al. 2021. The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin. FRONTIERS IN PHARMACOLOGY , vol.11 .

Fu, X., Eggert, M., Yoo, S., Patel, N., Zhong, J., Steinke, I., ... Govindarajulu, M.(2021). The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin. FRONTIERS IN PHARMACOLOGY , vol.11.

Fu, Xiaoyu Et Al. "The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin," FRONTIERS IN PHARMACOLOGY , vol.11, 2021

Fu, Xiaoyu Et Al. "The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin." FRONTIERS IN PHARMACOLOGY , vol.11, 2021

Fu, X. Et Al. (2021) . "The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin." FRONTIERS IN PHARMACOLOGY , vol.11.

@article{article, author={Xiaoyu Fu Et Al. }, title={The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin}, journal={FRONTIERS IN PHARMACOLOGY}, year=2021}